These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 14739939

  • 1. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L.
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [Abstract] [Full Text] [Related]

  • 2. Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.
    Lee SH, Bar-Haim E, Goldberger O, Reich-Zeliger S, Vadai E, Tzehoval E, Eisenbach L.
    Immunol Lett; 2004 Feb 15; 91(2-3):119-26. PubMed ID: 15019279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 15; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 6. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
    Zhang F, Chu X, Wang L, Zhu Y, Li L, Ma D, Peng J, Hou M.
    Eur J Haematol; 2006 May 15; 76(5):427-31. PubMed ID: 16480433
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS.
    J Immunol; 1998 Sep 15; 161(6):2848-55. PubMed ID: 9743345
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H, Hu HM, Urba WJ, Fox BA.
    J Immunol; 1999 Oct 15; 163(8):4462-72. PubMed ID: 10510388
    [Abstract] [Full Text] [Related]

  • 10. T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas.
    Sayers TJ, Brooks AD, Seki N, Smyth MJ, Yagita H, Blazar BR, Malyguine AM.
    J Leukoc Biol; 2000 Jul 15; 68(1):81-6. PubMed ID: 10914493
    [Abstract] [Full Text] [Related]

  • 11. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
    Sobek V, Balkow S, Körner H, Simon MM.
    Eur J Immunol; 2002 Sep 15; 32(9):2490-9. PubMed ID: 12207333
    [Abstract] [Full Text] [Related]

  • 12. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H.
    J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644
    [Abstract] [Full Text] [Related]

  • 13. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y, Thoburn CJ, Bright EC, Hess AD.
    Biol Blood Marrow Transplant; 2004 Mar 15; 10(3):156-70. PubMed ID: 14993881
    [Abstract] [Full Text] [Related]

  • 14. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
    Song K, Chang Y, Prud'homme GJ.
    Gene Ther; 2000 Sep 15; 7(18):1527-35. PubMed ID: 11021590
    [Abstract] [Full Text] [Related]

  • 15. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis.
    Bonetti B, Valdo P, Ossi G, De Toni L, Masotto B, Marconi S, Rizzuto N, Nardelli E, Moretto G.
    Glia; 2003 Aug 15; 43(2):141-8. PubMed ID: 12838506
    [Abstract] [Full Text] [Related]

  • 16. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA.
    J Immunol; 1999 Oct 15; 163(8):4335-41. PubMed ID: 10510373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
    Yoshida R, Sanchez-Bueno A, Yamamoto N, Einaga-Naito K.
    J Immunol; 1997 Jul 01; 159(1):15-21. PubMed ID: 9200433
    [Abstract] [Full Text] [Related]

  • 19. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G, Balkow S, Schimmer S, Schepers K, Simon MM, Dittmer U.
    Virology; 2004 Dec 20; 330(2):365-74. PubMed ID: 15567431
    [Abstract] [Full Text] [Related]

  • 20. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, Whitsett JA, Braciale TJ, Enelow RI.
    Am J Respir Cell Mol Biol; 1999 May 20; 20(5):849-58. PubMed ID: 10226053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.